About MAP/PATH
MAP/PATH L.L.C. is an early-stage company that in 2022 began work on a patented, rapid, over-the-counter (OTC) TB test. It has unique features that we believe will displace current TB testing practices.
Our novel product is based on patented methods for which we have an exclusive University of Minnesota patent option: Mycobacterium Biomarkers and Methods, Patent No.: US 10,324,090 Jun. 18, 2019; Option approved August 17, 2022. We seek to validate the claims of this patent and to broaden the base of our patent portfolio through additional proprietary concepts.
NEWS
MAP/PATH WINS AWARD IN MINNESOTA'S "WALLYEYE TANK" WINTER 2023 COMPETITION
Walleye Tank is Minnesota’s medical and life science pitch competition providing an educational and promotional opportunity for emerging and established medical and life science companies. MAP/PATH LLC was awarded the second place prize in the Winter 2023 competition held in December.
The competition is a collaboration between the Office of Entrepreneurship Mayo Clinic and University of Minnesota Technology Commercialization. Walleye Tank is curated by a diverse audience of investors and subject matter experts who guide entrepreneurs in every business development stage.
OUR TEAM
John Haaland, PhD | CEO & Co-Founder
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Thomas Dow, MD | President & Co-Founder
Seasoned biotechnology executive; former Senior Executive, VP Food Safety at Pillsbury; former CEO of Discovery Genomics (acquired by Immusoft, Inc.)
Thomas Dow, MD | President & Co-Founder
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Thomas Dow, MD | President & Co-Founder
Physician, researcher, and author; international expert on the association between MAP and human disease; a leader in communicating our TB Rapid Testing features; award-winner at the Minnesota Walleye Tank pitch competition Winter 2023
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Professor, Pathobiology & Diagnostic Investigation
Michigan State University; global expert on biomarkers in human and animal hosts; inventor of the 2019 University of Minnesota biomarker patent
Wendy Thanassi, MD | Consultant
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Srinand Sreevatsan, PhD | Executive Researcher & Science Advisor
Internationally recognized expert in infectious diseases, particularly tuberculosis screening; expert in TB workforce health and wellness programs; a TB lead in the Veteran's Health Administration (VHA)
Benjamin Hackel, PhD | Researcher & Science Advisor
Mike Collins, DVM, PhD | Science & Veterinary Advisor
Mike Collins, DVM, PhD | Science & Veterinary Advisor
Expert in protein engineering technologies and endolysins; Professor & Director of Graduate Studies in Chemical Engineering, University of Minnesota
Mike Collins, DVM, PhD | Science & Veterinary Advisor
Mike Collins, DVM, PhD | Science & Veterinary Advisor
Mike Collins, DVM, PhD | Science & Veterinary Advisor
Global expert on Johne’s Disease and MAP in ruminant animals; Professor, Pathobiological Sciences, University of Wisconsin